(Q45760964)

15 December 2017

title

DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus (English)

1 reference

15 December 2017

feline immunodeficiency virus

main subject

vector-borne disease

0 references

object named as

feline immunodeficiency virus

1 reference

Cuisinier AM

1

1 reference

15 December 2017

Mallet V

2

1 reference

15 December 2017

Meyer A

3

1 reference

15 December 2017

Caldora C

4

1 reference

15 December 2017

Aubert A

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

15

1 reference

15 December 2017

issue

10

1 reference

15 December 2017

page(s)

1085-1094

1 reference

15 December 2017

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Enhancement after feline immunodeficiency virus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

The development of a vaccine against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Passive antibody protection of cats against feline immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Evaluation of subunit vaccines against feline immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Serological responses of cats to feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900004-2

7 January 2021

10.1016/S0264-410X(97)00004-2

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9269051

1 reference

15 December 2017